Themis Medicare Ltd (THEMISMED) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Themis Medicare Ltd on NSE and BSE, with an AI summary of each filing.
Themis Medicare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
THEMISMED : 14-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2026, To consider and approve the un-audited standalone & consolidated financial results for the period ended September 30, 2026
Intimation · 14 Nov 2026, 5:30 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Acquisition/ Disposal of Shares · 30 Oct 2026, 4:14 pm
CTL Trusteeship Increases Pledged Stake in Themis Medicare to 35.09% CTL Trusteeship Limited reported an increase in encumbered equity shares of Themis Medicare Limited following a top-up trigger event under a debenture trust deed with OSS Software Solutions Labs Private Limited. Vividhmargi Trust pledged an additional 40,00,000 equity shares (4.34% stake)—comprising 15,00,000 shares on 22nd Oct'26 and 25,00,000 shares on 27th Oct'26. Consequently, total encumbered shares held by CTL Trusteeship rose from 2,83,17,620 shares (30.75%) to 3,23,17,620 shares, representing 35.09% of the company's total voting and diluted share capital.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 29 Oct 2026, 1:31 am
Themis Medicare Promoter Vividhmargi Investments Pledges 2.71% Stake Promoter entity Vividhmargi Investments Pvt. Ltd. created a pledge on 25,00,000 equity shares (2.71% of total share capital) of Themis Medicare Ltd. on 27th Oct'26. The pledge was executed in favor of CTL Trusteeship Ltd. for an NCD issuance by OSS Software Solutions Labs Pvt. Ltd. to Kotak Credit Opportunities Fund, involving debt of Rs. 135.00 cr. Post-transaction, Vividhmargi's encumbered holding increased from 4.89% (45,00,000 shares) to 7.60% (70,00,000 shares), out of its total 26.52% equity stake. Funds are earmarked for promoter/PAC personal use.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 28, 2026 for Vividhmargi Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 29 Oct 2026, 1:30 am
Vividhmargi Investments Pledges 2.71% Stake in Themis Medicare Limited Promoter entity Vividhmargi Investments Private Limited created a pledge on 25,00,000 equity shares (2.71% of total share capital) of Themis Medicare Limited on 27th Oct'26. The pledge was executed in favor of CTL Trusteeship Limited to secure unlisted, unrated NCDs issued by OSS Software Solutions Labs Private Limited for Kotak Credit Opportunities Fund, involving an amount of Rs 135 crore for personal promoter use. Following this transaction, Vividhmargi Investments' total encumbered shares increased to 70,00,000 shares, representing 7.60% of total share capital.
Themis Medicare Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
To consider and approve the un-audited standalone and consolidated financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Themis Medicare Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve un-audited standalone and consolidated ....
Intimation · 05 Nov 2026, 5:30 am
Themis Medicare Board to Consider Q2 FY27 Results on 5th Nov'26 Themis Medicare Limited has scheduled its Board of Directors meeting for 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside the Statutory Auditors' Limited Review Reports. In compliance with SEBI insider trading regulations, the trading window for designated persons remains closed from 1st Oct'26 until 48 hours post the publication of the financial results.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 24 Oct 2026, 4:04 pm
Vividhmargi Investments Pledges Additional 1.63% Stake in Themis Medicare Promoter entity Vividhmargi Investments Private Limited created a pledge on 15,00,000 equity shares (1.63% of total share capital) of Themis Medicare Limited on 22nd Oct'26. The pledge, valued at Rs. 16.84 cr, was executed in favor of CTL Trusteeship Limited to secure unlisted, non-convertible debentures of Rs. 135 cr issued by OSS Software Solutions Labs Private Limited for personal use by promoters and PACs. Following this transaction, Vividhmargi Investments' total encumbered holding increased from 30,00,000 shares (3.26%) to 45,00,000 shares (4.89%).
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 23, 2026 for Vividhmargi Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 24 Oct 2026, 4:02 pm
Themis Medicare Promoter Vividhmargi Investments Pledges 1.63% Stake Promoter entity Vividhmargi Investments Private Limited created a pledge on 15,00,000 equity shares (1.63% of total share capital) of Themis Medicare Limited on 22nd Oct'26. The pledge was executed in favor of CTL Trusteeship Limited for borrowings of Rs. 135 crore via unlisted NCDs issued by OSS Software Solutions Labs Private Limited, intended for promoter personal use. Following this creation, Vividhmargi Investments' total encumbered holding increased from 30,00,000 shares (3.26%) to 45,00,000 shares (4.89% of total equity). Total promoter group encumbrance stands at 2.43%.
Please refer to the intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
Others (Uncategorized) · 24 Oct 2026, 2:31 am
Themis Medicare Recommends Bhaskar Vemban Iyer's Re-appointment as Independent Director Themis Medicare's Board of Directors has recommended the re-appointment of Mr. Bhaskar Vemban Iyer as an Independent Director for a second consecutive term of five years, effective from 12th Nov'26, subject to shareholder approval. His first term concludes on 11th Nov'26. The company completed dispatching the Postal Ballot Notice to members on 23rd Oct'26 to seek requisite approval for the proposed tenure extension.
Kindly refer to our intimation of credit rating.
Others (Uncategorized) · 09 Oct 2026, 5:24 pm
CARE Downgrades Themis Medicare’s Bank Facilities Following Operational Weakness CARE Ratings downgraded Themis Medicare’s long-term bank facilities (₹77.39 crore) to 'CARE BB+; Stable' from 'CARE BBB-; Negative' and short-term facilities (₹48.50 crore) to 'CARE A4+' from 'CARE A3'. The downgrade reflects contracting operating scale, weak debt coverage, and severe margin compression in FY26, alongside a ₹51.43 crore PBILDT loss in Q1FY27 driven by one-time ECL and billing provisions. However, liquidity is partially buffered by ₹100 crore realized from selling GTBL shares, though promoter pledge rose to 43% as of 30th Jun'26.
Please refer to our Scrutinizer''s Report of 56th Annual General Meeting of the Company.
Annual General Meeting · 01 Oct 2026, 6:13 pm
Kindly refer to the attachment.
Annual General Meeting · 01 Oct 2026, 1:19 am
Themis Medicare Shareholders Approve All Resolutions at 56th AGM Themis Medicare Limited announced that shareholders approved all proposed resolutions with requisite majority at its 56th AGM held on 30th Sep'26. Total votes polled reached 36.12m across 92.10m outstanding shares, representing a 39.21% turnout. Key approvals included adoption of standalone and consolidated financial statements for the year ended 31st Mar'26, dividend declaration, re-appointment of director Rajneesh Anand (99.9964% in favor), ratification of cost auditor remuneration for FY26-27, and a special resolution amending the Articles of Association, all securing over 99.99% shareholder approval.
Intimation of revision in credit rating
Others (Uncategorized) · 01 Oct 2026, 12:45 am
CARE Ratings Downgrades Themis Medicare's Bank Facilities to CARE BB+ and CARE A4+ CARE Ratings has downgraded Themis Medicare's long-term bank facilities worth Rs 77.39 crore to 'CARE BB+; Stable' from 'CARE BBB-; Negative'. Additionally, the rating agency lowered the company's short-term bank facilities aggregating Rs 48.50 crore to 'CARE A4+' from 'CARE A3'. The total rated bank facilities stand at Rs 125.89 crore. The rating action follows a review of the company's operational and financial performance for FY26 (Audited) and Q1FY27 (Unaudited).
Please refer to the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 30 Sept 2026, 8:04 pm
Themis Medicare Shareholders Approve 50% Dividend and AOA Amendment Shareholders of Themis Medicare Limited have approved a dividend of Re. 0.50 per equity share (50% on a face value of Re. 1/- each) for the financial year ended 31st Mar'26, aggregating to an outlay of Rs. 4,60,50,060. Additionally, members approved an amendment to Article 13(1) Clause (c) of the Company's Articles of Association, removing the specific valuation report requirement previously stipulated for share issuances to designated persons for cash or other consideration.
Please refer to the attachment.
Others (Uncategorized) · 30 Sept 2026, 6:49 pm
Themis Medicare Concludes 56th AGM; Key Financial and Operational Resolutions Tabled Themis Medicare Limited conducted its 56th Annual General Meeting on 30th Sep'26, putting key ordinary and special resolutions forward for shareholder approval via remote e-voting and ballot paper. Key agenda items included the adoption of audited standalone and consolidated financial statements for the fiscal year ended 31st Mar'26, equity dividend declaration for FY26, the re-appointment of retiring director Mr. Rajneesh Anand, ratification of Cost Auditor remuneration for FY27, and amendments to the Articles of Association. Final voting results will be disseminated within two working days.
Kindly refer to the Outcome of 56th Annual General Meeting of the Company.
Annual General Meeting · 30 Sept 2026, 5:58 pm
Please refer to our intimation under Regulation 30 for withdrawal of proposed preferential issue of 45,95,795 convertible equity warrants.
Others (Uncategorized) · 25 Sept 2026, 1:11 am
Themis Medicare Withdraws Proposed Rs. 47.28 Crore Preferential Warrant Issue Themis Medicare Limited decided on 24th Sep'26 to withdraw its proposed preferential issue of 45,95,795 convertible equity warrants to promoter group entities at Rs. 102.87 per warrant, originally approved on 25th Feb'26. The issue was primarily intended to fund working capital requirements, which the company confirmed have now been arranged through other means. Themis Medicare will withdraw its in-principle approval applications from BSE and NSE, stating the decision will not adversely impact its financial position or ongoing operations.
Please refer to the attachment.
Dividend · 18 Sept 2026, 9:28 pm
Themis Medicare Fixes Record Date for FY26 Final Dividend Themis Medicare Limited has fixed 23rd Sep'26 as the record date to determine shareholder eligibility for the final dividend for the financial year ended 31st Mar'26. The dividend payout remains subject to shareholder approval at the company's 56th Annual General Meeting, which is scheduled to be held on 30th Sep'26.
Please refer to our BRSR for F.Y. 2025-26
Others (Uncategorized) · 09 Sept 2026, 3:42 am
Please refer to our Annual Report for F.Y. 2025-26
Others (Uncategorized) · 09 Sept 2026, 3:39 am
Please refer to the Notice of 56th AGM and Annual Report for F.Y. 2025-26
Annual General Meeting · 09 Sept 2026, 3:33 am
Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
Others (Uncategorized) · 17 Aug 2026, 10:01 pm
Themis Medicare Updates Key Contact and RTA Email Addresses Themis Medicare Limited announced key contact email changes effective 17th Aug'26. The new email for the Company Secretary/Compliance Officer is suresh.savaliya@themismedicare.com. Additionally, the email for its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, has been updated to investor.helpdesk@in.mpms.mufg.com. These changes are for all future investor communication and correspondence with the stock exchanges.